12
Participants
Start Date
April 1, 2024
Primary Completion Date
November 30, 2024
Study Completion Date
December 31, 2024
Dabigatran Etexilate
Subjects will receive a single oral dose of 110mg (low dose specification in the instructions) or lower of dabigatran etexilate on an empty stomach on the morning of day 1 and day 16 of the trial period.
D-mannose
Subjects will take 3g (1g\*3 tablets) of D-mannose tablets every morning and evening from the 2nd day to the 15th day of the trial period, with a total of 6g/day (medium dose specification in the instructions).
RECRUITING
Peking University Third Hospital, Beijing
Peking University Third Hospital
OTHER